Cancer Publications 2014

26 Jan 2023
26 Jan 2023
  1. Abratt, R.P., 2014. Neutron therapy and increased late complication rates. Radiotherapy and Oncology, 110(2), p.375.

  2. Aebi, S. et al., 2014. Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial. Lancet Oncology, 15(2), pp. 156-163.

  3. Angus, L., van der Watt, P.J. & Leaner, V.D., 2014. Inhibition of the nuclear transporter, Kpnβ1, results in prolonged mitotic arrest and activation of the intrinsic apoptotic pathway in cervical cancer cells. Carcinogenesis, 35(5), pp.1121–1131.

  4. Beckenkamp, A. et al., 2014. Ectonucleotidase expression profile and activity in human cervical cancer cell lines. Biochemistry and Cell Biology, 92(2), pp.95–104.

  5. Beeton-Kempen, N. et al., 2014. Development of a novel, quantitative protein microarray platform for the multiplexed serological analysis of autoantibodies to cancer-testis antigens. International Journal of Cancer, 135(8), pp.1842–1851.

  6. Bere, A. et al., 2014. Altered phenotype and function of NK cells infiltrating Human Papillomavirus (HPV)-associated genital warts during HIV infection. Clinical Immunology, 150(2), pp.210–219.

  7. Blum, D. et al., 2014. Self-report measurement of pain & symptoms in palliative care patients: a comparison of verbal, visual and hand scoring methods in Sub-Saharan Africa. Health and Quality of Life Outcomes, 12(1).

  8. Bohlius, J. et al., 2014. Kaposi's Sarcoma in HIV-infected patients in South Africa: multicohort study in the antiretroviral therapy era. International Journal of Cancer, 135(11), pp.2644-2652.

  9. Bruwer, Z. et al., 2013. Predictive Genetic Testing in Children: Constitutional Mismatch Repair Deficiency Cancer Predisposing Syndrome. Journal of Genetic Counseling, 23(2), pp.147–155.

  10. Cabrera-Fuentes, H. et al., 2014. RNase1 prevents the damaging interplay between extracellular RNA and tumour necrosis factor-α in cardiac ischaemia/reperfusion injury. Thrombosis and Haemostasis, 112(12), pp.1110–1119.

  11. Chellan, P. et al., 2014. Synthesis and evaluation of new polynuclear organometallic Ru(ii), Rh(iii) and Ir(iii) pyridyl ester complexes as in vitro antiparasitic and antitumor agents. Dalton Trans., 43(2), pp.513–526.

  12. Cox, S.G. et al., 2014. Magnetic Resonance Imaging Versus Histopathology in Wilms Tumor and Nephroblastomatosis. Journal of Pediatric Hematology/Oncology, 36(2), pp.e81–e84.

  13. Davidson, A. et al., 2014. Malignancies in South African children with HIV. Journal of Pediatric Hematology Oncology, 36(2), pp.111-117.

  14. Denny, L. et al., 2013. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa. International Journal of Cancer, 134(6), pp.1389–1398.

  15. DesRosiers, T. et al., 2014. A Hospital-Based Palliative Care Service for Patients With Advanced Organ Failure in Sub-Saharan Africa Reduces Admissions and Increases Home Death Rates. Journal of Pain and Symptom Management, 47(4), pp.786–792.

  16. Djansugurova, L. et al., 2014. Association of DCC, MLH1, GSTT1, GSTM1, and TP53 gene polymorphisms with colorectal cancer in Kazakhstan. Tumor Biology, 36(1), pp.279–289.

  17. Du Toit, J. et al., 2014. Orbital lymphomatoid granulomatosis – a rare cause of proptosis. Pediatric Radiology, 45(7), pp.1095–1098.

  18. Franz, D.N. et al., 2014. Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study. The Lancet Oncology, 15(13), pp.1513–1520.

  19. Geisler, K. et al., 2014. Nilotinib combined with interleukin-2 mediates antitumor and immunological effects in a B16 melanoma model. Oncology Reports, 31(5), pp.2015–2020.

  20. Gwyther, L., 2014. Palliative care in chronic disease. South African Medical Journal, 104(2), pp. 114-115.

  21. Hadley, K.E. & Hendricks, D.T., 2014. Use of NQO1 status as a selective biomarker for oesophageal squamous cell carcinomas with greater sensitivity to 17-AAG. BMC Cancer, 14(1).

  22. Hanks, S. et al., 2014. Germline mutations in the PAF1 complex gene CTR9 predispose to Wilms tumour. Nature Communications, 5(1).

  23. Harding, R. et al., 2014. Paediatric Palliative Care in Sub-Saharan Africa: A Systematic Review of the Evidence for Care Models, Interventions, and Outcomes. Journal of Pain and Symptom Management, 47(3), pp.642–651.

  24. Harding, R. et al., 2014. Wellbeing among sub-Saharan African patients with advanced HIV and/or cancer: an international multicentred comparison study of two outcome measures. Health and Quality of Life Outcomes, 12(1), p.80.

  25. Hartwig, Kristopher et al., 2014. Where there is no morphine: The challenge and hope of palliative care delivery in Tanzania. African Journal of Primary Health Care & Family Medicine, 6(1).

  26. Isaacs, A. et al., 2014. A snapshot of noncommunicable disease profiles and their prescription costs at ten primary healthcare facilities in the in the western half of the Cape Town Metropole. South African Family Practice, 56(1), pp.43–49.

  27. Karampelas, T. et al., 2014. GnRH-Gemcitabine Conjugates for the Treatment of Androgen-Independent Prostate Cancer: Pharmacokinetic Enhancements Combined with Targeted Drug Delivery. Bioconjugate Chemistry, 25(4), pp.813–823.

  28. Kleeman, B. et al., 2014. St John's Wort (Hypericum perforatum L.) Photomedicine: Hypericin-Photodynamic therapy induces metastatic melanoma cell death. PLoS One, 9(7), pp.1-20.

  29. Kruger, M. et al., 2013. Childhood cancer in Africa. Paediatric Blood & Cancer, 61(4), pp.587–592.

  30. Li, J. et al., 2014. The Anti-proliferative Function of the TGF-β1 Signaling Pathway Involves the Repression of the Oncogenic TBX2 by Its Homologue TBX3. Journal of Biological Chemistry, 289(51), pp.35633–35643.

  31. Mahomed, N. et al., 2014. Atypical teratoid/rhabdoid tumour in a supratentorial location: A report of two cases. South African Journal of Child Health, 8(4), p.159.

  32. Mbulawa, Z.Z. et al., 2014. Increased alpha-9 human papillomavirus species viral load in human immunodeficiency virus positive women. BMC Infectious Diseases, 14(1).

  33. Mbulawa, Z.Z.A. et al., 2014. Risk factors for oral human papillomavirus in heterosexual couples in an African setting. Journal of Infection, 68(2), pp.185–189.

  34. Melis, M. et al., 2014. Viral expression and molecular profiling in liver tissue versus microdissected hepatocytes in hepatitis B virus - associated hepatocellular carcinoma. Journal of Translational Medicine, 12(1).

  35. Mello, P. de A. et al., 2014. Adenosine uptake is the major effector of extracellular ATP toxicity in human cervical cancer cells C.-H. Heldin, ed. Molecular Biology of the Cell, 25(19), pp.2905–2918.

  36. Millar, A.J.W., 2014. Liver tumours in children: Current surgical management and role of Transplantation. South African Medical Journal, 104(11), p.813.

  37. Murray, S.A. et al., 2014. Promoting palliative care in the community: Production of the primary palliative care toolkit by the European Association of Palliative Care Taskforce in primary palliative care. Palliative Medicine, 29(2), pp.101–111.

  38. Nakash, O. et al., 2013. Comorbidity of common mental disorders with cancer and their treatment gap: findings from the World Mental Health Surveys. Psycho-Oncology, 23(1), pp.40–51.

  39. Paccez, J.D. et al., 2013. The receptor tyrosine kinase Axl in cancer: Biological functions and therapeutic implications. International Journal of Cancer, 134(5), pp.1024–1033.

  40.  Paleri, V. et al., 2014. Vascularized tissue to reduce fistula following salvage total laryngectomy: A systematic review. The Laryngoscope, 124(8), pp.1848–1853.

  41. Parkes, J. et al., 2014. SIOP PODC adapted treatment recommendations for standard-risk medulloblastoma in low and middle income settings. Pediatric Blood & Cancer, 62(4), pp.553–564.

  42. Powell, R.A. et al., 2014. Palliative Care Research in Africa: Consensus Building for a Prioritized Agenda. Journal of Pain and Symptom Management, 47(2), pp.315–324.

  43. Rice, J.C. et al., 2013. Brachytherapy and endoresection for choroidal melanoma: a cohort study. British Journal of Ophthalmology, 98(1), pp.86–91.

  44. Rohner, E. et al., 2014. Incidence Rate of Kaposi Sarcoma in HIV-Infected Patients on Antiretroviral Therapy in Southern Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes, 67(5), pp.547–554.

  45. Sales, K.J. et al., 2014. CCR5 expression is elevated in cervical cancer cells and is up-regulated by seminal plasma. MHR: Basic science of reproductive medicine, 20(11), pp.1144–1157.

  46. Sayed, S. et al., 2014. Is breast cancer from Sub Saharan Africa truly receptor poor? Prevalence of ER/PR/HER2 in breast cancer from Kenya. The Breast, 23(5), pp.591–596.

  47. Schäfer, G. & Kaschula, C., 2014. The Immunomodulation and Anti-Inflammatory Effects of Garlic Organosulfur Compounds in Cancer Chemoprevention. Anti-Cancer Agents in Medicinal Chemistry, 14(2), pp.233–240.

  48. Senkus, E. et al., 2013. Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3-98. Psycho-Oncology, 23(2), pp.173–182.

  49. Sewram, V. et al., 2014. Diet and Esophageal Cancer Risk in the Eastern Cape Province of South Africa. Nutrition and Cancer, 66(5), pp.791–799.

  50. Shamley, D., Lascurain-Aguirrebeña, I. & Oskrochi, R., 2013. Clinical anatomy of the shoulder after treatment for breast cancer. Clinical Anatomy, 27(3), pp.467–477.

  51. Siegert, R. et al., 2014. A Psychometric Evaluation of the Functional Assessment of Chronic Illness Therapy-Palliative Care (FACIT-Pal) Scale With Palliative Care Samples in Three African Countries. Journal of Pain and Symptom Management, 48(5), pp.983–991.

  52. Smit, B.J. & van Wijk, A.L., 2013. An improved  disposable indwelling intrauterine tube ("Smit Sleeve") not requiring    retaining stitches for brachy-radiotherapy for carcinoma of the cervix. European Journal of Gynaecological Oncology, 34(4), pp.289-290.

  53. Spearman, C.W.N. & Sonderup, M.W., 2014. Preventing hepatitis B and hepatocellular carcinoma in South Africa: The case for a birth-dose vaccine. South African Medical Journal, 104(9), p.610.

  54. Stannard, C. et al., 2014. Iodine-125 brachytherapy in the management of squamous cell carcinoma of the oral cavity and oropharynx. Brachytherapy, 13(4), pp.405–412.

  55. Steffen, J. et al., 2013. Identification of ocular surface squamous neoplasia by in vivo staining with methylene blue. British Journal of Ophthalmology, 98(1), pp.13–15.

  56. Stephenson, K.A. & Fagan, J.J., 2014. Effect of perioperative proton pump inhibitors on the incidence of pharyngocutaneous fistula after total laryngectomy: A prospective randomized controlled trial. Head & Neck, 37(2), pp.255–259.

  57. Stupart, D. et al., 2013. No evidence of genetic anticipation in a large family with Lynch syndrome. Familial Cancer, 13(1), pp.29–34.

  58. Stupart, D. et al., 2014. Fertility and apparent genetic anticipation in Lynch syndrome. Familial Cancer, 13(3), pp.369–374.

  59. Tan, J.Y. et al., 2014. Cross-talking noncoding RNAs contribute to cell-specific neurodegeneration in SCA7. Nature Structural & Molecular Biology, 21(11), pp.955–961.

  60. Tathiah, N. et al., 2014. Cervical cancer in South Africa:  challenges and opportunities. In South African Health Review 2013/14. Chapter 11, pp.117-125.

  61. Van Der Watt, P.J. et al., 2014. Elevated expression of the nuclear export protein, Crm1 (exportin 1), associates with human oesophageal squamous cell carcinoma. Oncology Reports, 32(2), pp.730–738.

  62. Van Niekerk, L. & Raubenheimer, P.J., 2013. A point-prevalence survey of public hospital inpatients with palliative care needs in Cape Town, South Africa. South African Medical Journal, 104(2), p.138.

  63. Végran, F. et al., 2014. The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells. Nature Immunology, 15(8), pp.758–766.

  64. Vogelsang, M. et al., 2014. Aberrant methylation of the MSH3 promoter and distal enhancer in esophageal cancer patients exposed to first-hand tobacco smoke. Journal of Cancer Research and Clinical Oncology, 140(11), pp.1825–1833.

  65. Wansleben, S., Peres, J., Hare, S., Goding, C.R. & Prince, S. 2014. T-box transcription factors in cancer biology. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1846(2), pp.380-391.

  66. Zerbini, L.F. et al., 2014. Computational Repositioning and Preclinical Validation of Pentamidine for Renal Cell Cancer. Molecular Cancer Therapeutics, 13(7), pp.1929–1941.